 Promoter deletion loss retinoblastoma gene expression human prostate carcinoma Mutational inactivation retinoblastoma gene RB retinoblastomas subset human neoplasms sarcomas bone soft tissue carcinomas lung breast Exogenous copies wild-type RB tumorigenicity several types tumor cells endogenous RB mutations human prostatic carcinoma cell line support role RB inactivation genesis prostate cancer primary metastatic prostate carcinoma specimens evidence RB mutation use immunoblot analysis immunostaining histologic sections RB-encoded protein tumor cells specimens specimen absent tumor cells specimen RB mutations latter case deletion nucleotides transcriptional start sites ii loss second RB allele deletion sufficient promoter activity upstream DNA sequences heterologous expression system results demonstrate RB vivo mutation promoter ii existence RB mutations human prostate carcinomas iii use immunohistochemical methods RB mutations clinical samples common adult neoplasms